Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J MONTERO

Showing results (541-550 of 552) with videos related to

Pageof 56
Sort By:
Ebiomedicine|March 12, 2023
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidenceAntonio C Fuentes-Fayos, Miguel E G-García, Jesús M Pérez-Gómez, et al.
Biology|December 30, 2025
Comparative Genomic and Microenvironmental Profiles of Hereditary and Sporadic TNBC in Colombian WomenYina T Zambrano-Ordoñez, Alejandro Mejía-Garcia, Julieta M Ramírez-Mejía, et al.
Leukemia|July 24, 2015
Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG miceJ Etchin, J Montero, A Berezovskaya, et al.
Ebiomedicine|January 7, 2020
Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancerJuan M Jiménez-Vacas, Vicente Herrero-Aguayo, Antonio J Montero-Hidalgo, et al.
Science Advances|October 2, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancerAntonio J Montero-Hidalgo, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2022
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD TrialFrancois-Clement Bidard, Virginia G Kaklamani, Patrick Neven, et al.
Cell Genomics|March 23, 2023
<i>In vivo</i> interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolutionAnja Fischer, Robert Lersch, Niklas de Andrade Krätzig, et al.
Medcomm|June 10, 2026
The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal AdenocarcinomaJanine Murr, Carolin Schneider, Ningjun Duan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 12, 2026
The telomerase/shelterin system is impaired in acromegaly and Cushing´s disease: Potential pathophysiological relevanceMiguel E G-García, Ana S De la Rosa-Herencia, Ignacio Gil-Duque, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|November 14, 2024
[Epidemiological and clinical management aspects related to urinary tract infections diagnosed in the emergency department in elderly patients in Spain: Results of the EDEN-36 study]O J Salmerón Béliz, E Pérez-Fernández, O Miró, et al.
Pageof 56

Showing results (541-550 of 552) with videos related to

Sort By:
Pageof 56
Ebiomedicine|March 12, 2023
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidenceAntonio C Fuentes-Fayos, Miguel E G-García, Jesús M Pérez-Gómez, et al.
Biology|December 30, 2025
Comparative Genomic and Microenvironmental Profiles of Hereditary and Sporadic TNBC in Colombian WomenYina T Zambrano-Ordoñez, Alejandro Mejía-Garcia, Julieta M Ramírez-Mejía, et al.
Leukemia|July 24, 2015
Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG miceJ Etchin, J Montero, A Berezovskaya, et al.
Ebiomedicine|January 7, 2020
Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancerJuan M Jiménez-Vacas, Vicente Herrero-Aguayo, Antonio J Montero-Hidalgo, et al.
Science Advances|October 2, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancerAntonio J Montero-Hidalgo, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2022
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD TrialFrancois-Clement Bidard, Virginia G Kaklamani, Patrick Neven, et al.
Cell Genomics|March 23, 2023
<i>In vivo</i> interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolutionAnja Fischer, Robert Lersch, Niklas de Andrade Krätzig, et al.
Medcomm|June 10, 2026
The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal AdenocarcinomaJanine Murr, Carolin Schneider, Ningjun Duan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 12, 2026
The telomerase/shelterin system is impaired in acromegaly and Cushing´s disease: Potential pathophysiological relevanceMiguel E G-García, Ana S De la Rosa-Herencia, Ignacio Gil-Duque, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|November 14, 2024
[Epidemiological and clinical management aspects related to urinary tract infections diagnosed in the emergency department in elderly patients in Spain: Results of the EDEN-36 study]O J Salmerón Béliz, E Pérez-Fernández, O Miró, et al.
Pageof 56